Malisorn N. New promising agents, boceprevir and telapevir, for new standard care for the treatment of chronic HCV infection. J Basic App Pharmacol [internet]. 2015 Mar. 18 [cited 2026 Aug. 30];35(1):41-54. available from: https://li01.tci-thaijo.org/index.php/JBAP/article/view/32172